These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 28324303)

  • 21. Stability of motor-nonmotor subtype in early-stage Parkinson's disease.
    Xiao Y; Wei Q; Ou R; Hou Y; Zhang L; Liu K; Lin J; Yang T; Jiang Q; Shang H
    Front Aging Neurosci; 2022; 14():1040405. PubMed ID: 36437989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New markers in Parkinson's disease.
    Bougea A
    Adv Clin Chem; 2020; 96():137-178. PubMed ID: 32362317
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A critical appraisal of the premotor symptoms of Parkinson's disease: potential usefulness in early diagnosis and design of neuroprotective trials.
    Lang AE
    Mov Disord; 2011 Apr; 26(5):775-83. PubMed ID: 21484865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Parkinson's Disease Subtyping Using Clinical Features and Biomarkers: Literature Review and Preliminary Study of Subtype Clustering.
    Lee SH; Park SM; Yeo SS; Kwon O; Lee MK; Yoo H; Ahn EK; Jang JY; Jang JH
    Diagnostics (Basel); 2022 Jan; 12(1):. PubMed ID: 35054279
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Can Biomarkers Help the Early Diagnosis of Parkinson's Disease?
    Le W; Dong J; Li S; Korczyn AD
    Neurosci Bull; 2017 Oct; 33(5):535-542. PubMed ID: 28866850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical phenotype of drug-naïve Parkinson's disease based on nonmotor symptoms.
    Lee HM; Lee SS; Kim M; Kang SH; Seo WK; Kim JH; Koh SB
    Arch Gerontol Geriatr; 2015; 61(3):517-22. PubMed ID: 26183203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nonmotor predictors for levodopa requirement in de novo patients with Parkinson's disease.
    Erro R; Picillo M; Amboni M; Moccia M; Vitale C; Longo K; Pellecchia MT; Santangelo G; Martinez-Martin P; Chaudhuri KR; Barone P
    Mov Disord; 2015 Mar; 30(3):373-8. PubMed ID: 25648938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of the progression of Parkinson's disease: a metabolic network approach.
    Eckert T; Tang C; Eidelberg D
    Lancet Neurol; 2007 Oct; 6(10):926-32. PubMed ID: 17884682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical subtypes of Parkinson's disease.
    van Rooden SM; Colas F; Martínez-Martín P; Visser M; Verbaan D; Marinus J; Chaudhuri RK; Kok JN; van Hilten JJ
    Mov Disord; 2011 Jan; 26(1):51-8. PubMed ID: 21322019
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advances in Biomarker Research in Parkinson's Disease.
    Mehta SH; Adler CH
    Curr Neurol Neurosci Rep; 2016 Jan; 16(1):7. PubMed ID: 26711276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical evolution of Parkinson's disease and prognostic factors affecting motor progression: 9-year follow-up study.
    Reinoso G; Allen JC; Au WL; Seah SH; Tay KY; Tan LC
    Eur J Neurol; 2015 Mar; 22(3):457-63. PubMed ID: 24888502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Personalized Medicine and Nonmotor Symptoms in Parkinson's Disease.
    Titova N; Chaudhuri KR
    Int Rev Neurobiol; 2017; 134():1257-1281. PubMed ID: 28805572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonmotor symptoms in Parkinson's disease: expanding the view of Parkinson's disease beyond a pure motor, pure dopaminergic problem.
    Sung VW; Nicholas AP
    Neurol Clin; 2013 Aug; 31(3 Suppl):S1-16. PubMed ID: 23931951
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nonmotor symptoms in essential tremor: Comparison with Parkinson's disease and normal control.
    Lee SM; Kim M; Lee HM; Kwon KY; Koh SB
    J Neurol Sci; 2015 Feb; 349(1-2):168-73. PubMed ID: 25641389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical subtypes and genetic heterogeneity: of lumping and splitting in Parkinson disease.
    von Coelln R; Shulman LM
    Curr Opin Neurol; 2016 Dec; 29(6):727-734. PubMed ID: 27749396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Challenges in the diagnosis of Parkinson's disease.
    Tolosa E; Garrido A; Scholz SW; Poewe W
    Lancet Neurol; 2021 May; 20(5):385-397. PubMed ID: 33894193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New Symptomatic Treatments for the Management of Motor and Nonmotor Symptoms of Parkinson's Disease.
    Taddei RN; Spinnato F; Jenner P
    Int Rev Neurobiol; 2017; 132():407-452. PubMed ID: 28554417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic markers for Parkinson's disease.
    Chahine LM; Stern MB
    Curr Opin Neurol; 2011 Aug; 24(4):309-17. PubMed ID: 21464716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Nonmotor Features of Parkinson's Disease.
    Titova N; Qamar MA; Chaudhuri KR
    Int Rev Neurobiol; 2017; 132():33-54. PubMed ID: 28554413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biomarkers of Nonmotor Symptoms in Parkinson's Disease.
    Konno T; Al-Shaikh RH; Deutschländer AB; Uitti RJ
    Int Rev Neurobiol; 2017; 133():259-289. PubMed ID: 28802922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.